Perioperative glycemic control: An evidence-based review

Anesthesiology

Volumn 110, Issue 2, 2009, Pages 408-421

  Lipshutz, Angela K M ^a   Gropper, Michael A ^b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT;

ANESTHESIST; BLOOD GLUCOSE MONITORING; CLINICAL PROTOCOL; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; GLYCEMIC CONTROL; HEALTH CARE POLICY; HEART SURGERY; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE UNIT; INTRAOPERATIVE PERIOD; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PERIOPERATIVE PERIOD; POPULATION RECOVERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; BLOOD; CLINICAL TRIAL; COST BENEFIT ANALYSIS; CRITICAL ILLNESS; GLUCOSE BLOOD LEVEL; INTENSIVE CARE; METABOLISM; MORTALITY; MULTICENTER STUDY; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; RISK FACTOR;

BLOOD GLUCOSE; COST-BENEFIT ANALYSIS; CRITICAL ILLNESS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE; INTRAOPERATIVE COMPLICATIONS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 61549089984     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181948a80     Document Type: Review

References (109)

1. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-67
2. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A: Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003; 125:1007-21
3. Ouattara A, Lecomte P, Le Manach Y, Landi M, Jacqueminet S, Platonov I, Bonnet N, Riou B, Coriat P: Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. ANESTHESIOLOGY 2005; 103:687-94
4. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, Williams BA, Schrader LM, Rizza RA, McMahon MM: Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc 2005; 80:862-6
5. Doenst T, Wijeysundera D, Karkouti K, Zechner C, Maganti M, Rao V, Borger MA: Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2005; 130:1144.e1-1144.e8
6. Thomas MC, Mathew TH, Russ GR, Rao MM, Moran J: Early peri-operative glycaemic control and allograft rejection in patients with diabetes mellitus: A pilot study. Transplantation 2001; 72:1321-4
7. Bilotta F, Spinelli A, Giovannini F, Doronzio A, Delfini R, Rosa G: The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: A randomized prospective pilot trial. J Neurosurg Anesthesiol 2007; 19:156-60
8. Azevedo JR, Lima ER, Cossetti RJ, Azevedo RP: Intensive insulin therapy versus conventional glycemic control in patients with acute neurological injury: A prospective controlled trial. Arq Neuropsiquiatr 2007; 65:733-8
9. Malmberg K, Ryden L, Hamsten A, Herlitz J, Waldenstrom A, Wedel H: Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI study group. diabetes insulin-glucose in acute myocardial infarction. Eur Heart J 1996; 17:1337-44
10. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R: Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-61
11. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K: German Competence Network Sepsis (Sep-Net): Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125-39
12. Preiser JC: Restoring normoglycaemia: Not so harmless. Crit Care 2008; 12:116
13. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O'Brien PC, Johnson MG, Williams AR, Cutshall SM, Mundy LM, Rizza RA, McMahon MM: Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: A randomized trial. Ann Intern Med 2007; 146: 233-43
14. Federico F: Preventing harm from high-alert medications. Jt Comm J Qual Patient Saf 2007; 33:537-42
15. Montori VM, Bistrian BR, McMahon MM: Hyperglycemia in acutely ill patients. JAMA 2002; 288:2167-9
16. Inzucchi SE: Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med 2006; 355:1903-11
17. McCowen KC, Malhotra A, Bistrian BR: Stress-induced hyperglycemia. Crit Care Clin 2001; 17:107-24
18. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P: Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31:359-66
19. Ellger B, Debaveye Y, Vanhorebeek I, Langouche L, Giulietti A, Van Etten E, Herijgers P, Mathieu C, Van den Berghe G: Survival benefits of intensive insulin therapy in critical illness: Impact of maintaining normoglycemia versus glycemiaindependent actions of insulin. Diabetes 2006; 55:1096-105
20. Vanhorebeek I, Langouche L, Van den Berghe G: Glycemic and nonglycemic effects of insulin: How do they contribute to a better outcome of critical illness? Curr Opin Crit Care 2005; 11:304-11
21. Bagry HS, Raghavendran S, Carli F: Metabolic syndrome and insulin resistance: Perioperative considerations. ANESTHESIOLOGY 2008; 108:506-23
22. Krinsley JS: Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004; 79:992-1000
23. Turina M, Fry DE, Polk HC Jr: Acute hyperglycemia and the innate immune system: Clinical, cellular, and molecular aspects. Crit Care Med 2005; 33:1624-33
24. Langouche L, Vanhorebeek I, Vlasselaers D, Vander Perre S, Wouters PJ, Skogstrand K, Hansen TK, Van den Berghe G: Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 2005; 115:2277-86
25. Vanhorebeek I, De Vos R, Mesotten D, Wouters PJ, De Wolf-Peeters C, Van den Berghe G: Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 2005; 365:53-9
26. Mesotten D, Swinnen JV, Vanderhoydonc F, Wouters PJ, Van den Berghe G: Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab 2004; 89:219-26
27. Langouche L, Vander Perre S, Wouters PJ, D'Hoore A, Hansen TK, Van den Berghe G: Effect of intensive insulin therapy on insulin sensitivity in the critically ill. J Clin Endocrinol Metab 2007; 92:3890-7
28. Yu WK, Li WQ, Li N, Li JS: Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations. World J Gastroenterol 2003; 9:1824-7
29. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress. Circulation 2002; 106:2067-72
30. Finney SJ, Zekveld C, Elia A, Evans TW: Glucose control and mortality in critically ill patients. JAMA 2003; 290:2041-7
31. Rady MY, Johnson DJ, Patel BM, Larson JS, Helmers RA: Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus. Mayo Clin Proc 2005; 80:1558-67
32. Auer RN: Hypoglycemic brain damage. Metab Brain Dis 2004; 19:169-75
33. Cryer PE, Davis SN, Shamoon H: Hypoglycemia in diabetes. Diabetes Care 2003; 26:1902-12
34. Vriesendorp TM, DeVries JH, van Santen S, Moeniralam HS, de Jonge E, Roos YB, Schultz MJ, Rosendaal FR, Hoekstra JB: Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med 2006; 34:2714-8
35. Ingels C, Debaveye Y, Milants I, Buelens E, Peeraer A, Devriendt Y, Vanhoutte T, Van Damme A, Schetz M, Wouters PJ, Van den Berghe G: Strict blood glucose control with insulin during intensive care after cardiac surgery: Impact on 4-years survival, dependency on medical care, and quality-of-life. Eur Heart J 2006; 27:2716-24
36. Bellomo R, Egi M: Glycemic control in the intensive care unit: Why we should wait for NICE-SUGAR. Mayo Clin Proc 2005; 80:1546-8
37. Marik PE, Varon J: Intensive insulin therapy in the ICU: Is it now time to jump off the bandwagon? Resuscitation 2007; 74:191-3
38. Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F, Bouillon R, Schetz M: Intensive insulin therapy in mixed medical/surgical intensive care units: Benefit versus harm. Diabetes 2006; 55:3151-9
39. Vriesendorp TM, van Santen S, DeVries JH, de Jonge E, Rosendaal FR, Schultz MJ, Hoekstra JB: Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med 2006; 34:96-101
40. Krinsley JS, Grover A: Severe hypoglycemia in critically ill patients: Risk factors and outcomes. Crit Care Med 2007; 35:2262-7
41. th Critical Care Congress, Orlando, Florida, February 17-21, 2007
42. Ellger B, van den Heuvel I, Poelaert J: Insulin and pentastarch for severe sepsis. N Engl J Med 2008; 358:2073-4; author reply 2074-5
43. Van den Berghe G, Wilmer A, Bouillon R: Insulin and pentastarch for severe sepsis. N Engl J Med 2008; 358:2073; author reply 2074-5
44. Lacherade JC, Outin H, De Jonghe B: Insulin and pentastarch for severe sepsis. N Engl J Med 2008; 358:2071-2; author reply 2074-5
45. Wiener RS, Wiener DC, Larson RJ: Benefits and risks of tight glucose control in critically ill adults: A meta-analysis. JAMA 2008; 300:933-44
46. Finfer S, Delaney A: Tight glycemic control in critically ill adults. JAMA 2008; 300:963-5
47. Mehta SR, Yusuf S, Diaz R, Zhu J, Pais P, Xavier D, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L, CREATE-ECLA Trial Group Investigators: Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: The CREATE-ECLA randomized controlled trial. JAMA 2005; 293:437-46
48. Scott JF, Robinson GM, French JM, O'Connell, JE Alberti KG, Gray CS: Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: The glucose insulin in stroke trial (GIST). Stroke 1999; 30:793-9
49. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A: Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997; 63:356-61
50. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A: Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999; 67:352-60; discussion 360-2
51. Schmeltz LR, DeSantis AJ, Thiyagarajan V, Schmidt K, O'Shea-Mahler E, Johnson D, Henske J, McCarthy PM, Gleason TG, McGee EC, Molitch ME: Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy. Diabetes Care 2007; 30:823-8
52. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL: Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 1999; 22:1408-14
53. van der Horst IC, Timmer JR, Ottervanger JP, Bilo HJ, Gans RO, de Boer MJ, Zijlstra F: GIPS Investigators: Glucose-insulin-potassium and reperfusion in acute myocardial infarction: Rationale and design of the glucose-insulin- potassium study-2 (GIPS-2). Am Heart J 2005; 149:585-91
54. Lazar HL, Philippides G, Fitzgerald C, Lancaster D, Shemin RJ, Apstein C: Glucose-insulin-potassium solutions enhance recovery after urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg 1997; 113:354-60; discussion 360-2
55. Rao V, Christakis GT, Weisel RD, Ivanov J, Borger MA, Cohen G: The insulin cardioplegia trial: Myocardial protection for urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg 2002; 123:928-35
56. Lazar HL, Chipkin S, Philippides G, Bao Y, Apstein C: Glucose-insulinpotassium solutions improve outcomes in diabetics who have coronary artery operations. Ann Thorac Surg 2000; 70:145-50
57. Furnary AP, Wu Y, Bookin SO: Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: The Portland diabetic project. Endocr Pract 2004;10 Suppl 2:21-33
58. D'Alessandro C, Leprince P, Golmard JL, Ouattara A, Aubert S, Pavie A, Gandjbakhch I, Bonnet N: Strict glycemic control reduces EuroSCORE expected mortality in diabetic patients undergoing myocardial revascularization. J Thorac Cardiovasc Surg 2007; 134:29-37
59. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS: Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004; 109:1497-502
60. Vriesendorp TM, Morelis QJ, Devries JH, Legemate DA, Hoekstra JB: Early post-operative glucose levels are an independent risk factor for infection after peripheral vascular surgery. A retrospective study. Eur J Vasc Endovasc Surg 2004; 28:520-5
61. Pasternak JJ, McGregor DG, Lanier WL: Effect of single-dose dexamethasone on blood glucose concentration in patients undergoing craniotomy. J Neurosurg Anesthesiol 2004; 16:122-5
62. Lukins MB, Manninen PH: Hyperglycemia in patients administered dexamethasone for craniotomy. Anesth Analg 2005; 100:1129-33
63. Hawkins JS, Casey BM: Labor and delivery management for women with diabetes. Obstet Gynecol Clin North Am 2007; 34:323-34
64. Curet LB, Izquierdo LA, Gilson GJ, Schneider JM, Perelman R, Converse J: Relative effects of antepartum and intrapartum maternal blood glucose levels on incidence of neonatal hypoglycemia. J Perinatol 1997; 17:113-5
65. Kline GA, Edwards A: Antepartum and intra-partum insulin management of type 1 and type 2 diabetic women: Impact on clinically significant neonatal hypoglycemia. Diabetes Res Clin Pract 2007; 77:223-30
66. Balsells M, Corcoy R, Adelantado JM, Garcia-Patterson A, Altirriba O, de Leiva A: Gestational diabetes mellitus: Metabolic control during labour. Diabetes Nutr Metab 2000; 13:257-62
67. ACOG Committee on Practice Bulletins: ACOG practice bulletin. clinical management guidelines for obstetrician-gynecologists. number 60, march 2005. pregestational diabetes mellitus. Obstet Gynecol 2005; 105:675-85
68. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA: Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358:1991-2002
69. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP: MiG Trial Investigators: Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008; 358:2003-15
70. Atkinson MA, Maclaren NK: The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994; 331:1428-36
71. Bode BW, Braithwaite SS, Steed RD, Davidson PC: Intravenous insulin infusion therapy: Indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract 2004; 10 Suppl 2:71-80
72. Krinsley JS: Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003; 78:1471-8
73. Egi M, Bellomo R, Stachowski E, French CJ, Hart G: Variability of blood glucose concentration and short-term mortality in critically ill patients. ANESTHESIOLOGY 2006; 105:244-52
74. Ali N, O'Brien J, Dungan K, Phillips G, Marsh C, Lemeshow S, Connors A, Preiser JC: Glucose variability is independently associated with mortality in patients with sepsis. Crit Care Med. 2007; 36:A257
75. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006; 295:1681-7
76. Desachy A, Vuagnat AC, Ghazali AD, Baudin OT, Longuet OH, Calvat SN, Gissot V: Accuracy of bedside glucometry in critically ill patients: Influence of clinical characteristics and perfusion index. Mayo Clin Proc 2008; 83:400-5
77. Kanji S, Buffie J, Hutton B, Bunting PS, Singh A, McDonald K, Fergusson D, McIntyre LA, Hebert PC: Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med 2005; 33:2778-85
78. Fahy BG, Coursin DB: Critical glucose control: The devil is in the details. Mayo Clin Proc 2008; 83:394-7
79. Finkielman JD, Oyen LJ, Afessa B: Agreement between bedside blood and plasma glucose measurement in the ICU setting. Chest 2005; 127:1749-51
80. Soo Hoo GW, Vanhorebeek I, Van den Berghe G: Tight blood glucose control in the ICU: How best to measure glucose control? Chest 2008; 133:316-7
81. Vogelzang M, van der Horst IC, Nijsten MW: Hyperglycaemic index as a tool to assess glucose control: A retrospective study. Crit Care 2004; 8:R122-7
82. Egi M, Bellomo R, Stachowski E, French CJ, Hart G, Stow P: Circadian rhythm of blood glucose values in critically ill patients. Crit Care Med 2007; 35:416-21
83. Carvalho G, Moore A, Qizilbash B, Lachapelle K, Schricker T: Maintenance of normoglycemia during cardiac surgery. Anesth Analg 2004; 99:319-24
84. Goldberg PA, Siegel MD, Sherwin RS, Halickman JI, Lee M, Bailey VA, Lee SL, Dziura JD, Inzucchi SE: Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 2004; 27:461-7
85. Goldberg PA, Sakharova OV, Barrett PW, Falko LN, Roussel MG, Bak L, Blake-Holmes D, Marieb NJ, Inzucchi SE: Improving glycemic control in the cardiothoracic intensive care unit: Clinical experience in two hospital settings. J Cardiothorac Vasc Anesth 2004; 18:690-7
86. McMullin J, Brozek J, McDonald E, Clarke F, Jaeschke R, Heels-Ansdell D, Leppert R, Foss A, Cook D: Lowering of glucose in critical care: A randomized pilot trial. J Crit Care 2007; 22:112-8; discussion 118-9
87. Miriam A, Korula G: A simple glucose insulin regimen for perioperative blood glucose control: The vellore regimen. Anesth Analg 2004; 99:598-602
88. Chaney MA, Nikolov MP, Blakeman BP, Bakhos M: Attempting to maintain normoglycemia during cardiopulmonary bypass with insulin may initiate postoperative hypoglycemia. Anesth Analg 1999; 89:1091-5
89. Meijering S, Corstjens AM, Tulleken JE, Meertens JH, Zijlstra JG, Ligtenberg JJ: Towards a feasible algorithm for tight glycaemic control in critically ill patients: A systematic review of the literature. Crit Care 2006; 10:R19
90. Balkin M, Mascioli C, Smith V, Alnachawati H, Mehrishi S, Saydain G, Slone H, Alessandrini J, Brown L: Achieving durable glucose control in the intensive care unit without hypoglycaemia: A new practical IV insulin protocol. Diabetes Metab Res Rev 2007; 23:49-55
91. Lipshutz AK, Fee C, Schell H, Campbell L, Taylor J, Sharpe BA, Nguyen J, Gropper MA: Strategies for success: A PDSA analysis of three QI initiatives in critical care. Jt Comm J Qual Patient Saf 2008; 34:435-44
92. Newton CA, Young S: Financial implications of glycemic control: Results of an inpatient diabetes management program. Endocr Pract 2006; 12 Suppl 3:43-8
93. Krinsley JS, Jones RL: Cost analysis of intensive glycemic control in critically ill adult patients. Chest 2006; 129:644-50
94. Van den Berghe G, Wouters PJ, Kesteloot K, Hilleman DE: Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med 2006; 34:612-6
95. Wachter RM, Foster NE, Dudley RA: Medicare's decision to withhold payment for hospital errors: The devil is in the det. Jt Comm J Qual Patient Saf 2008; 34:116-23
96. Pronovost PJ, Goeschel CA, Wachter RM: The wisdom and justice of not paying for "preventable complications." JAMA 2008; 299:2197-9
97. Bailey TS, Zisser HC, Garg SK: Reduction in hemoglobin A1C with realtime continuous glucose monitoring: Results from a 12-week observational study. Diabetes Technol Ther 2007; 9:203-10
98. Corstjens AM, Ligtenberg JJ, van der Horst IC, Spanjersberg R, Lind JS, Tulleken JE, Meertens JH, Zijlstra JG: Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients. Crit Care 2006; 10:R135
99. Goldberg PA, Siegel MD, Russell RR, Sherwin RS, Halickman JI, Cooper DA, Dziura JD, Inzucchi SE: Experience with the continuous glucose monitoring system in a medical intensive care unit. Diabetes Technol Ther 2004; 6:339-47
100. Bochicchio GV, Bochicchio KM, Lettich K, Lambert P, Herrera A, Lumpkins K, Scalea TM, Magarian P: Cutting edge technology in tight glycemic control (TGC). Crit Care Med 2007; 35 (suppl):A142
101. Rood E, Bosman RJ, van der Spoel JI, Taylor P, Zandstra DF: Use of a computerized guideline for glucose regulation in the intensive care unit improved both guideline adherence and glucose regulation. J Am Med Inform Assoc 2005; 12:172-80
102. Plank J, Blaha J, Cordingley J, Wilinska ME, Chassin LJ, Morgan C, Squire S, Haluzik M, Kremen J, Svacina S, Toller W, Plasnik A, Ellmerer M, Hovorka R, Pieber TR: Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients. Diabetes Care 2006; 29:271-6
103. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV: Fully automated closed-loop insulin delivery versus semi-automated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008; 31:934-9
104. Renard E, Costalat G, Chevassus H, Bringer J: Artificial beta-cell: Clinical experience toward an implantable closed-loop insulin delivery system. Diabetes Metab 2006; 32:497-502
105. Chase JG, Shaw GM, Lin J, Doran CV, Hann C, Lotz T, Wake GC, Broughton B: Targeted glycemic reduction in critical care using closed-loop control. Diabetes Technol Ther 2005; 7:274-82
106. Chee F, Fernando T, van Heerden PV: Closed-loop glucose control in critically ill patients using continuous glucose monitoring system (CGMS) in real time. IEEE Trans Inf Technol Biomed 2003; 7:43-53
107. Chee F, Fernando T, van Heerden PV: Closed-loop control of blood glucose levels in critically ill patients. Anaesth Intensive Care 2002; 30: 295-307
108. London MJ: Quo vadis, perioperative beta blockade? are you "POISE'd" on the brink? Anesth Analg 2008; 106:1025-30
109. Toft P, Jorgensen HS, Toennesen E, Christiansen C: Intensive insulin therapy to non-cardiac ICU patients: A prospective study. Eur J Anaesthesiol 2006; 23:705-9